Results 91 to 100 of about 51,092 (200)

Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays

open access: yesTherapeutic Advances in Gastroenterology, 2017
Background: The commercialization of CT-P13, an infliximab (IFX) biosimilar, has the potential to decrease health-related costs and enhance access to biological therapies.
Joana Afonso   +5 more
doaj   +1 more source

Reproducibility (test-retest) of vestibular evoked myogenic potential

open access: yesBrazilian Journal of Otorhinolaryngology, 2015
INTRODUCTION: There is still no consensus in the literature as to the best acoustic stimulus for capturing vestibular evoked myogenic potential (VEMP). Low-frequency tone bursts are generally more effective than high-frequency, but recent studies still ...
Aline Cabral de Oliveira   +2 more
doaj   +1 more source

t(11;17)(p15;p13) [PDF]

open access: yes, 2009
Review on t(11;17)(p15;p13), with data on clinics, and the genes ...
Huret, JL
core   +1 more source

t(5;17)(q33;p13) [PDF]

open access: yes, 2009
Review on t(5;17)(q33;p13), with data on clinics, and the genes ...
Huret, JL
core   +1 more source

t(2;9)(p11;p13) [PDF]

open access: yes, 2006
Review on t(2;9)(p11;p13), with data on clinics, and the genes ...
Huret, JL
core   +1 more source

A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population

open access: yesBiologics: Targets & Therapy, 2018
Yusuf Yazici,1 Lin Xie,2 Adesuwa Ogbomo,2 Lorie A Ellis,3 Kavitha Goyal,4 Amanda Teeple,5 Ece A Mutlu,6 Ismail Simsek7 1Department of Internal Medicine, Division of Rheumatology, New York University Hospital for Joint Diseases, New York, NY, USA ...
Yazici Y   +7 more
doaj  

CT-P13: design, development, and place in therapy

open access: yesDrug Design, Development and Therapy, 2017
Tommaso Gabbani,1 Simona Deiana,2 Vito Annese3 1Gastroenterology Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì, 2Division of Gastroenterology, AOU Careggi University Hospital, Florence, Italy; 3Gastroenterology Department, Valiant ...
Gabbani T, Deiana S, Annese V
doaj  

Mosaic distal 13q duplication due to mosaic unbalanced translocation of 46,XY,der(14)t(13;14)(q32.2;p13)/46,XY at amniocentesis in a pregnancy associated with a favorable fetal outcome, perinatal progressive decrease of the aneuploid cell line and cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes

open access: yesTaiwanese Journal of Obstetrics & Gynecology
Objective: We present mosaic distal 13q duplication due to mosaic unbalanced translocation 46,XY,der(14)t(13;14)(q32.2;p13)/46,XY at amniocentesis in a pregnancy associated with a favorable fetal outcome.
Chih-Ping Chen   +9 more
doaj   +1 more source

Two cases of myeloid disorders and a t(8;12) (q12;p13)

open access: yesHaematologica, 2000
BACKGROUND AND OBJECTIVE: Rearrangements of the short arm of chromosome 12 have been described in different hematologic malignancies. Some of these abnormalities showed a rearrangement of the ETV6 gene. We studied the 12p region in one case with a t(8;12)
JM Hernandez   +6 more
doaj  

The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis

open access: yesBMC Gastroenterology
Background Since 2015, an infliximab biosimilar, CT-P13, has been approved for commercial use in many countries, easing the economic burden borne by society and patients.
Xinyue Hu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy